GL1X · GenesisL1 explorer

MolNFT v1 · #103345 · protein

Crystal structure of escherchia COLI uncharacterized protein yjcs

4PDX · Putative ALKYL/ARYL-sulfatase yjcs: “Crystal structure of escherchia COLI uncharacterized protein yjcs”. X-ray diffraction, 1 ligand (SO4), 20 pockets (best druggability 0.85). MolNFT v1 #103345 on GenesisL1: 3D structure, binding…

PDB
4PDX
Type
protein
Length
1,241 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Putative ALKYL/ARYL-sulfatase yjcs
EC
3.1.6.-
UniProt
P32717
Ligands
SO4
Pockets
20 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APutative ALKYL/ARYL-sulfatase yjcs (EC 3.1.6.-)protein62242% helix, 16% strandP32717
BPutative ALKYL/ARYL-sulfatase yjcs (EC 3.1.6.-)protein61942% helix, 15% strandP32717

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14760.850.9243empty
210690.840.8594SO4
35910.710.7949SO4
44120.650.7935GOL
54410.650.7834SO4, GOL

Interfaces

1 interface between chains.

  • A–B · 5320 Ų buried · 88 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 32 modified (engineered).

Compared structures

  • 4PDX · Crystal structure of Escherchia coli uncharacterized protein YjcS · the same entry in another collection · chain A against A, TM-score 1.00
  • P32717 · AlphaFold monomer V2.0 prediction for putative ALKYL/ARYL-sulfatase yjcs (P32717) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.